Cardiology Update London 2022
-
Ort
London
Type of event
on site
Invitation
Dear Colleagues
It is a real pleasure to welcome you the 6th Christmas Postgraduate Course of the Royal Brompton and Harefield NHS Foundation Trust & Imperial College, the Cardiology Update London.
Cardiology and cardiovascular medicine in general is a rapidly expanding field with impressive developments and innovations over the last years. For physicians, be it general practitioners, cardiologists or cardiac surgeons, it is therefore important to keep pace with a challenging environment. To that end, we have designed a postgraduate course, the Cardiology Update London, to summarize, at the end of the year, the most important new developments, innovations, but also failures that will all affect cardiovascular diagnosis and management in our everyday practice.
We have selected an international Faculty of high standing experts both from the Trust and worldwide, covering the broad spectrum of cardiovascular medicine from prevention to intervention, from valvular heart disease to heart failure, and from conservative management to intervention and surgical operations. Thus, the course will give an up-to-date overview about current diagnosis and management of the most important cardiovascular conditions during two days in London.
We are delighted to welcome you at the Royal Society of Medicine in central London to enjoy two days of interactive education for the benefit of your practice and your patients.
Yours sincerely,
Prof. Thomas F. Lüscher
MD, FRPC, FESC
Dr. Richard Grocott-Mason
MD, FRCP
Prof. Kim Fox
MD, FRCP, FESC
Dr. Bernard J. Gersh
FACC
Prof. Peter Libby
FACC
Dr. Ruth Amstein
FESC
In collaboration with
Under the Auspices of
Programme
Programme Overview
| Monday , December 12th (UK Time) | Tuesday, December 13th (UK Time) | ||
|---|---|---|---|
| 8:30 | Welcome Address Opening Lectures
|
8:30 | Session 4 Arrhythmias, Sudden Cardiac Death
|
| 9:45 | Coffee | 10:30 | Coffee |
| 10:15 | Session 1 Risk Factors and Prevention Guidelines
|
11:00 | Session 5 Valve Disease
|
| 12:30 | Satellite Symposium | 12:30 | Satellite Symposium |
| 13:15 | Lunch Break | 13:15 | Lunch Break |
| 14:00 | The Paul Hamilton Wood Lecture The HF Saga (M. Packer) |
||
| 14:00 | Session 2 Acute and Chronic Coronary Syndromes
|
14:30 | Session 6 Heart Failure: Established and Novel Drugs / Advanced Stage
|
| 16:15 | Coffee | 15:45 | Coffee |
| 16:45 | Satellite Symposium | ||
| 17:15 | Session 3 The new ESC Guidelines
|
16:00 | Session 7 Heart, Kidney and Amyloidosis
|
| 18:15 | Networking Reception | 17:15 | Adjourn |
Scientific Programme
Monday, December 12th, 2022 (UK time)
Venue: The Royal Society of Medicine
| 08:30-09:00 | Welcome Address | |||||
| 08:30 | Welcome by the ESC President: The future of Cardiology in Europe |
Thomas F. Lüscher, London | |||
| 08:45 - 09:45 | Opening Lectures: Frontiers in Cardiovascular Science Chair: Thomas F. Lüscher, London and Filippo Crea, Rome |
||
| 08:45 | Opening Lectures 1: The vulnerable patient: Imaging residual inflammatory cardiovascular risk |
Charalambos Antoniades, Oxford |
| 09:15 | Opening Lecture 2: Digital health in current clinical practice |
Martin Cowie, London |
| 09:45- 10:15 COFFEE BREAK | ||
| 10:15 - 12:30 | Session 1: Risk Factors and Prevention Chairs: Mahmoud Barbier, Harefield and Ulf Landmesser, Berlin |
||
| 10:15 | Mischief in the marrow: A root of cardiovascular diseases | Peter Libby, Boston |
| 10:35 | RNA interference to treat hyperlipidaemia | Ulf Landmesser, Berlin |
| 10:55 | Novel antilipidaemic drugs | François Mach, Geneva |
| 11:15 | Lipoprotein(a) – the Cinderella of lipid management (Apollo Trial) | Børge Nordestgaard,Copenhagen |
| 11:35 | Heart age: A new concept to implement prevention | John Deanfield, London |
| 11:55 | Panel Discussion | All |
| 12:30 - 13:15 | Industry sponsored symposium | ||
| 13:15-14:00 Lunch Buffet | ||
| 14:00 - 16:15 | Session 2: Acute and Chronic Coronary Syndromes Chairs: Richard Grocott-Mason, London and Peter Libby, Boston |
||
| 14:00 | Which imaging modality to diagnose ischemia? (PACIFIC and DISCHARGE Trials) |
Ibrahim Danad, Amsterdam |
| 14:15 | What is predictive in CCS: Ischemia or coronary anatomy? | Bernard J. Gersh, Rochester MN |
| 14:30 | Patient case TBD | Majid Akhtar, London |
| 14:45 | Inflammation and ACS | Filippo Crea, Rome |
| 15:00 | Acute management of ACS: What we think we know and what we would like to know in the future | Adrian Banning, Oxford |
| 15:15 | Effects of PCSK9 inhibition on coronary atherosclerosis and AMI (PACMAN AMI Trial) | Lorenz Räber, Berne |
| 15:30 | Towards personal antithrombotic management in ACS | Thomas F. Lüscher, London |
| 15:45 | Panel Discussion | All |
| 16:15- 16:45 COFFEE BREAK | ||
| 16:45 - 17:15 | Industry sponsored symposium |
| 17:15 - 18:45 | Session 3: The new ESC 2022 Guidelines Chairs: François Mach, Geneva and Bernard J. Gersh, Rochester MN |
||
| 17:15 | Pulmonary Hypertension | Stephan Rosenkranz, Cologne |
| 17:30 | Q&A | |
| 17:40 | Cardio-Oncology | Alexander Lyon, London |
| 17:55 | Q&A | |
| 18:05 | Cardiovascular management of patients with non-cardiac surgery | Julinda Mehilli, Landshut-Achdorf |
| 18:20 | Q&A | |
| 18:45 Get Together Reception | ||
Tuesday, December 13th, 2022
Venue: The Royal Society of Medicine
| 08:30 - 10:30 | Session 4: Arrhythmias, Sudden Cardiac Death Chairs: John Camm, London and Vias Markides, London |
||
| 08:30 | 2022 ESC Guidelines on Ventricular Arrhythmias and SCD | Jacob Tfelt-Hansen, Copenhagen |
| 08:50 | My patient with ventricular arrhythmias | Shouvik Haldar, London |
| 09:10 | Myocardial fibrosis and SCD | Sanjay Prasad, London |
| 09:30 | Long Covid, PODS and other conditions | Betty Raman, Oxford |
| 09:50 | Atrial fibrillation 2022 | Gerhard Hindricks, Leipzig |
| 10:10 | Panel discussion | All |
| 10:30-11:00 | COFFEE BREAK | |
| 11:00- 12:30 | Session 5: Valve Disease Chairs: Miles Dalby, London and Volkmar Falk, Berlin |
||
| 11:00 | Advanced imaging in aortic stenosis | Jeroen J. Bax, Leiden |
| 11:20 | TAVI, the default option in aortic stenosis? | Stephan Windecker, Berne |
| 11:40 | Mitral valve disease: Knife or clip? | Francesco Maisano, Milano |
| 12:00 | Tricuspid regurgitation, a new therapeutic target | Georg Nickenig, Bonn |
| 12:20 | Panel discussion | All |
| 12:30 - 13:15 | Industry Sponsored Symposium | ||
| 13:15-14:00 Lunch Buffet |
| 14:00 - 14:30 | The Paul Hamilton Wood Lecture Chairs: Bernard J. Gersh, Rochester MN and Thomas F. Lüscher, London |
|||||
| The Heart Failure Saga | Milton Packer, Dallas | ||||
| 14:30 - 15:45 | Session 6: Heart Failure: Established and Novel Drugs / Advanced Stage Chairs: Paul Kalra, Portsmouth and Giuseppe Rosano, London |
||
| 14:30 | Guideline-directed medical therapy in HFrEF | Theresa McDonagh, London |
| 14:50 | New and emerging therapies in HF: Cyclic GMP activation and beyond | Piotr Ponikowski, Wrozlaw |
| 15:10 | Mechanical circulatory support for destination therapy | Volkmar Falk, Berlin |
| 15:30 | Panel discussion | All |
| 15:45 - 16:00 COFFEE BREAK | ||
| 16:00 - 17:15 | Session 7: Heart, Kidney and Amyloidosis Chairs: Bernard J. Gersh, Rochester and Antonis Pantazis, London |
||
| 16:00 | Kidney protection by SGLT2 inhibitors | Christoph Wanner, Würzburg |
| 16:20 | Clinical use of biomarkers in HF | Alan Maisel, San Diego |
| 16:40 | New treatment options in transthyretin amyloid | Martha Grogan, Rochester MN |
| 17:00 | Panel discussion | All |
| 17:15 | Wrap-up and Adjourn | Thomas F. Lüscher, London |
Updated: 22.11.2022
Information
Registration
| Category | |
|---|---|
| Registration fees | |
| Regular fee | GBP 300 |
| Early registration fee (until November 11, 2022) | GBP 250 |
| ESC / Association Members | |
| Regular fee | GBP 250 |
| Early registration fee (until November 11, 2022) | GBP 200 |
| Trainees/Residents, Research fellows, Nurses, Students <40 years (ID proof required)* | |
| Regular fee | GBP 150 |
| Early registration fee (until November 11, 2022) | GBP 100 |
| Day Ticket | GBP 150 |
| Group Registration (For group registrations a minimum of 10 participants is required)** | |
| Regular fee | GBP 260 |
| Early registration fee (until November 11, 2022) | GBP 210 |
*For the reduced registration (Trainees/Residents, Research fellows, Nurses, Students <35 years) please send a copy of your ID to Ms. Nadine-Estelle Kaltheuner at nadine-estelle.kaltheuner@zhh.ch.
**Please contact Ms. Nadine-Estelle Kaltheuner (nadine-estelle.kaltheuner@zhh.ch) at the Zurich Heart House to obtain further information.
Registration will be confirmed upon receipt of payment.
Please note that UK banks may charge high fees for international bank transfers. We therefore recommend payment by credit card.
Modification & Cancellation
All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to the Zurich Heart House. For each modification requested by the participant, GBP 50 will be charged for administrative costs. In case of cancel-lation up to 1st of November 2022, deposits will be refunded less 35 % for administrative costs. After this date, no refund will be possible.
Organisation
Zurich Heart House, Foundation for Cardiovascular Research
Dr. Ruth Amstein
Nadine-Estelle Kaltheuner
Hottingerstrasse 14, CH-8032 Zurich, Switzerland
Phone +41 (0) 44 250 40 95, Fax +41 (0) 44 250 40 90
Accreditation
The Cardiology Update London is recognised by the following institutions as accredited continuing education:
- Federation of the Royal Colleges of Physicians of the United Kingdom for CPD credits 13 category 1 (external) CPD credits
The Cardiology Update London is submitted to the following institutions as accredited continuing education:
- EACCME-UEMS European Accreditation Council for Continuing Medical Education (EACCME® ) 13 European CME credits (ECMEC®s)